학술논문
Phase I Dose Escalation Trial Of The DLL3/CD3 Igg-Like T Cell Engager BI 764532 In Patients with DLL3+Tumors: Focus on SCLC
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15561380